The possibilities of combination immunotherapy with radiation therapy for the treatment of patients with inoperable locally advanced non-small cell lung cancer

Currently, lung cancer is a global problem and public health issue in the world. Chemoradiotherapy remains the optimal method in the treatment of patients with unresectable non-small cell lung cancer (NSCLC). Nowadays, immune response checkpoint inhibitors (monoclonal antibodies) are actively introd...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: E. I. Smolenov, G. V. Afonin, V. S. Usachev, D. D. Kudryavtsev, I. V. Kolobaev, S. A. Ivanov
Формат: Artigo
Язык:Russo
Опубликовано: QUASAR, LLC 2021-06-01
Серии:Issledovaniâ i Praktika v Medicine
Предметы:
non-small cell lung cancer
nsclc
radiotherapy
chemotherapy
immunotherapy
monoclonal antibody
pd inhibitor
chemoradiotherapy
Online-ссылка:https://www.rpmj.ru/rpmj/article/view/727
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы